Beese Fulmer Investment Management Inc. Has $12.15 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Beese Fulmer Investment Management Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 23,190 shares of the healthcare conglomerate’s stock after selling 81 shares during the period. Beese Fulmer Investment Management Inc.’s holdings in UnitedHealth Group were worth $12,146,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Waycross Partners LLC boosted its stake in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $515,000. Full Sail Capital LLC boosted its stake in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $39,413,000. Finally, Silvercrest Asset Management Group LLC boosted its stake in shares of UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after purchasing an additional 12,550 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on UNH. Morgan Stanley cut their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 14th. Mizuho lowered their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. JPMorgan Chase & Co. lowered their price objective on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a research report on Thursday, May 15th. Oppenheimer lowered their price objective on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Finally, Robert W. Baird lowered their price objective on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $441.87.

UnitedHealth Group Trading Up 1.0%

Shares of UnitedHealth Group stock opened at $301.08 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The stock has a 50 day moving average price of $430.87 and a two-hundred day moving average price of $494.23. The stock has a market capitalization of $273.12 billion, a PE ratio of 19.42, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period last year, the business posted $6.91 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the business’s stock in a transaction on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Kristen Gil acquired 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.